Neptune UK Mid Cap fund manager Mark Martin looks at the prospects for companies in the out of favour pharmaceutical industry.
Neil Woodford's love of pharmaceutical companies has been well publicised over the past few years, but the income investor has been particularly excited about the prospects of a company using pieces of pig to regrow human tissue.
Healthcare property is opening up new opportunities for investors, writes Maria Merricks.
Investing in healthcare is more than just a play on the well-documented ageing population trend. Maria Merricks reports.
AXA Investment Managers has hired a portfolio manager for its Healthcare fund to strengthen the team following a spate of departures.
AXA Investment Managers is to hand its Health and Biotech funds to Mark Hargraves and Bruno Grandsard on a temporary basis.
Deane Donnigan has resigned from AXA Investment Managers, and will exit the group in June.